Share on LinkedInShare on LinkedIn

PODCAST · 20 DECEMBER 2024

New HSR Rules: Impacts To The Pharma Industry (Podcast)

Ropes & Gray LLP
Ropes & Gray LLP
Contributor
Ropes & Gray LLP

Ropes & Gray LLP

Ropes & Gray is one of the world’s most respected law firms, with offices in key business and...

View firm profile
Explore more from Ropes & Gray LLP

On this Ropes & Gray podcast, strategic transactions partner Hannah England is joined by antitrust partners Jackie Grise and Zak Goodwin to discuss the practical implications of the new Hart–Scott–Rodino ("HSR") Act rules...

United StatesAntitrust/Competition Law

Speakers: Hannah H. England (Freeman), Jacqueline Grise, Zachary D. Goodwin

On this Ropes & Gray podcast, strategic transactions partner Hannah England is joined by antitrust partners Jackie Grise and Zak Goodwin to discuss the practical implications of the new Hart–Scott–Rodino ("HSR") Act rules, which go into effect on February 10, 2025, and the challenges faced by pharmaceutical clients and the strategic adjustments required for compliance. Tune in to understand how these changes will affect acquisitions, licensing and collaboration transactions and other strategic transactions, as well as the overall regulatory landscape.

Transcript:

Hannah England: Hello, and welcome to our Ropes & Gray podcast series on the new Hart–Scott–Rodino ("HSR") Act rules, with this first episode focused on impacts to the pharmaceutical industry. My name is Hannah England, and I'm a partner in our strategic transactions practice based in Boston. I represent large

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from